EUCRATES BIOMEDICAL ACQUISITION CORP.EUCRW 0.18
EPS (as of 2022-12-31)
Use left/right arrow keys to switch.Breakdowns
Name | Value |
---|
Revenues | 0.0K |
Cost of Revenue | 0.0K |
Gross Profit | 0.0K |
Operating Expense | 263.2K |
Operating I/L | -263.2K |
Other Income/Expense | 404.9K |
Interest Income | 289.1K |
Pretax | 141.8K |
Income Tax Expense | -404.9K |
Net Income/Loss | 546.7K |
Eucrates Biomedical Acquisition Corp.
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.